Do you think diabetes or when you become pre-diabetic, it would have symptoms to show?Diabetes is defined as fasting blood glucose level of 126 mg/dL or higher, or a glycated hemoglobin level ...

New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...

By Dr. Sanchari Sinha Dutta, Ph.D. A large Danish trial analysis suggests high-dose flu vaccines may offer extra protection ...

Recently, the results of the pivotal Phase III clinical trial (EECOH-1) of ecnoglutide injection, developed by Sciwind ...

Sciwind Biosciences Co., Ltd. ('Sciwind'), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced today that China's National ...

Researchers have conducted the most comprehensive analysis to date linking plasma proteins to genetic variation in ...

The biopharmaceutical company released phase three clinical data for its type two diabetes treatment ecnoglutide in the peer-reviewed scientific journal.

Effective prevention and management of T2DM can improve patient outcomes and reduce health care-related environmental impact.

Replacing habitual artificial sweetened beverage intake with water does not improve glycemic outcomes or HbA1c levels in ...

Researchers conducted an observational cross-sectional study to assess how interoceptive awareness affects recognition of hypoglycemia in type 1 diabetes.

By Tarun Sai Lomte From rising obesity and diabetes to stubborn health inequities, the AHA’s latest statistics reveal why ...

The gut microbiome has been a rising star in the world of health science over the last several years, garnering interest from both researchers and the general public. This is mostly due to its ...